Recently, Yu et al. [33] discovered a HER2 gene amplification/mutation in the single CTCs isolated from an advanced breast cancer patient by Whole-genome sequencing, which was not identified in the primary tumour. This evidence concerns the gene ERBB2 and breast carcinoma.